FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315157042> ?p ?o ?g. }

• W2315157042 abstract "We previously showed that 5-amino-4-imidazolecarboxamide riboside (Z) potentiates methotrexate (MTX) uptake in human leukemia CCRF-CEM cells via the reduced folate carrier (RFC) and also enhances MTX growth inhibitory potency. We have now studied the role of protein kinases (PK) in Z-mediated potentiation of MTX uptake. AMP-activated PK (AMPK), the prototypical target of Z, was not involved because an AMPK activator (D942) alone did not potentiate MTX uptake and an AMPK inhibitor (compound C) did not inhibit Z-mediated potentiation. We then assessed the ability of a PK inhibitor library to inhibit Z-mediated potentiation of [ 3 H]MTX uptake. None of the 80 PK inhibitors at 10 µM affected MTX uptake in the absence of Z. At 10 µM, triciribine (Akt), GF 109203X and Ro 31-8220 (both pan-PKC) demonstrated the greatest inhibition (>78%) of Z potentiation, with IC 50 values of 4 µM, 1.8 µM and 1.7 µM, respectively. These data suggest that Akt and/or PKC (classical, c; novel, n; or atypical, a) could be involved in Z potentiation. Further studies with phorbol 12-myristate 13-acetate, which can selectively modulate activity of cPKC and nPKC (but not aPKC), and with PKC isotype-specific inhibitors suggested that cPKC and nPKC are not involved, but aPKC (PKC-ι and/or PKC-ζ) are. Expression of PKC-ι but not PKC-ζ in CCRF-CEM cells indicated PKC-ι to be the most likely candidate. Our PK inhibitor screen would identify inhibitors of Z transport and metabolism, as well as of Z-potentiated RFC function. Our previous findings revealed that Z must enter CCRF-CEM cells via equilibrative nucleoside transporter-1 (ENT-1) and that Z potentiates MTX uptake in a concentration-dependent manner. It was reported by others that PKC-δ and/or -e enhance nucleoside uptake through ENT-1 in other cell types. To investigate if PKC can regulate transport/metabolism of Z, which could ultimately affect Z potentiation, a modified transport assay and HPLC analysis were used to quantitate intracellular [ 14 C]Z ± pan-PKC inhibitor GF 109203X. GF 109203X decreased cellular Z accumulation by 54 ± 0.7% at 20 min, with an 86 ± 6.5% lower Z monophosphate (ZMP) level. Together with the results above, these data suggest that PKC-ι enhances Z accumulation and ZMP levels, which could potentiate MTX uptake. Further studies are underway investigating the effect of PKC-ι on Z transport alone by measuring the effect of GF 109203X on [ 14 C]Z uptake at 10 sec. In addition, Akt inhibitor, triciribine, also decreased cellular [ 14 C]Z accumulation by 48 ± 7.8%. Current evidence showing a role for PKC-ι and/or Akt in Z-potentiated MTX uptake may be partly or largely due to their effects on Z transport/metabolism, rather than on RFC. Because potentiation of MTX uptake requires Z transport and metabolism and at least 1 potentiating process, direct studies on posttranslational modification of RFC may provide better insight into possible mechanisms of Z-potentiated MTX uptake. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3583." @default.
• W2315157042 created "2016-06-24" @default.
• W2315157042 creator A5033243205 @default.
• W2315157042 creator A5041348263 @default.
• W2315157042 creator A5054096287 @default.
• W2315157042 creator A5091214681 @default.
• W2315157042 date "2010-04-15" @default.
• W2315157042 modified "2023-09-27" @default.
• W2315157042 title "Abstract 3583: 5-Amino-4-imidazolecarboxamide riboside-potentiated methotrexate uptake in CCRF-CEM cells" @default.
• W2315157042 doi "https://doi.org/10.1158/1538-7445.am10-3583" @default.
• W2315157042 hasPublicationYear "2010" @default.
• W2315157042 type Work @default.
• W2315157042 sameAs 2315157042 @default.
• W2315157042 citedByCount "0" @default.
• W2315157042 crossrefType "proceedings-article" @default.
• W2315157042 hasAuthorship W2315157042A5033243205 @default.
• W2315157042 hasAuthorship W2315157042A5041348263 @default.
• W2315157042 hasAuthorship W2315157042A5054096287 @default.
• W2315157042 hasAuthorship W2315157042A5091214681 @default.
• W2315157042 hasConcept C170493617 @default.
• W2315157042 hasConcept C184235292 @default.
• W2315157042 hasConcept C185592680 @default.
• W2315157042 hasConcept C195794163 @default.
• W2315157042 hasConcept C25274449 @default.
• W2315157042 hasConcept C2776328115 @default.
• W2315157042 hasConcept C2780043322 @default.
• W2315157042 hasConcept C2780124434 @default.
• W2315157042 hasConcept C55493867 @default.
• W2315157042 hasConcept C62478195 @default.
• W2315157042 hasConcept C75217442 @default.
• W2315157042 hasConcept C86803240 @default.
• W2315157042 hasConcept C88045685 @default.
• W2315157042 hasConcept C97029542 @default.
• W2315157042 hasConcept C98274493 @default.
• W2315157042 hasConceptScore W2315157042C170493617 @default.
• W2315157042 hasConceptScore W2315157042C184235292 @default.
• W2315157042 hasConceptScore W2315157042C185592680 @default.
• W2315157042 hasConceptScore W2315157042C195794163 @default.
• W2315157042 hasConceptScore W2315157042C25274449 @default.
• W2315157042 hasConceptScore W2315157042C2776328115 @default.
• W2315157042 hasConceptScore W2315157042C2780043322 @default.
• W2315157042 hasConceptScore W2315157042C2780124434 @default.
• W2315157042 hasConceptScore W2315157042C55493867 @default.
• W2315157042 hasConceptScore W2315157042C62478195 @default.
• W2315157042 hasConceptScore W2315157042C75217442 @default.
• W2315157042 hasConceptScore W2315157042C86803240 @default.
• W2315157042 hasConceptScore W2315157042C88045685 @default.
• W2315157042 hasConceptScore W2315157042C97029542 @default.
• W2315157042 hasConceptScore W2315157042C98274493 @default.
• W2315157042 hasLocation W23151570421 @default.
• W2315157042 hasOpenAccess W2315157042 @default.
• W2315157042 hasPrimaryLocation W23151570421 @default.
• W2315157042 hasRelatedWork W1257992088 @default.
• W2315157042 hasRelatedWork W1882562518 @default.
• W2315157042 hasRelatedWork W1969710944 @default.
• W2315157042 hasRelatedWork W1973119852 @default.
• W2315157042 hasRelatedWork W1975738308 @default.
• W2315157042 hasRelatedWork W1987196091 @default.
• W2315157042 hasRelatedWork W1996035906 @default.
• W2315157042 hasRelatedWork W2008338411 @default.
• W2315157042 hasRelatedWork W2026930564 @default.
• W2315157042 hasRelatedWork W2045067656 @default.
• W2315157042 hasRelatedWork W2052999444 @default.
• W2315157042 hasRelatedWork W2055804474 @default.
• W2315157042 hasRelatedWork W2074275745 @default.
• W2315157042 hasRelatedWork W2078669391 @default.
• W2315157042 hasRelatedWork W2112309605 @default.
• W2315157042 hasRelatedWork W2147197274 @default.
• W2315157042 hasRelatedWork W2152603461 @default.
• W2315157042 hasRelatedWork W2187559175 @default.
• W2315157042 hasRelatedWork W2417895027 @default.
• W2315157042 hasRelatedWork W2468687393 @default.
• W2315157042 isParatext "false" @default.
• W2315157042 isRetracted "false" @default.
• W2315157042 magId "2315157042" @default.
• W2315157042 workType "article" @default.